Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof

作者: Kenneth K. Iwata , J. Gordon Foulkes , John D. Haley , Peter Ten Dijke

DOI:

关键词:

摘要: The present invention provides a method for inhibiting cytotoxic poisoning of normal cells in subject which comprises administering to the an amount Transforming Growth Factor Beta effective slow growth and thereby inhibit subject. Typically, administration is topical initiated prior anti-neoplastic therapy such as radiation treatment or chemotherapy. particularly suited pediatric patients.

参考文章(65)
R. Derynck, P. B. Lindquist, A. Lee, D. Wen, J. Tamm, J. L. Graycar, L. Rhee, A. J. Mason, D. A. Miller, R. J. Coffey, A new type of transforming growth factor-beta, TGF-beta 3. The EMBO Journal. ,vol. 7, pp. 3737- 3743 ,(1988) , 10.1002/J.1460-2075.1988.TB03257.X
Joel B. Epstein, The Painful Mouth: Mucositis, Gingivitis, and Stomatitis Infectious Disease Clinics of North America. ,vol. 2, pp. 183- 202 ,(1988) , 10.1016/S0891-5520(20)30173-2
Michael J. Newman, Tgf-b compositions and method ,(1990)
Richard K. Assoian, Charles A. Frolik, Anita B. Roberts, Michael B. Sporn, Purified transforming growth factor-beta derived from human platelets and placentas ,(1984)
Dagne L. Florine, Thomas J. Smith, Treatment and prevention of oral mucositis with growth factors ,(1990)
J R Florini, A B Roberts, D Z Ewton, S L Falen, K C Flanders, M B Sporn, Transforming growth factor-beta. A very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by Buffalo rat liver cells. Journal of Biological Chemistry. ,vol. 261, pp. 16509- 16513 ,(1986) , 10.1016/S0021-9258(18)66595-0